# DESCRIPTION

- introduce tuberculosis infection status
- motivate need for accurate diagnosis
- describe limitations of current diagnostic tests
- highlight importance of early diagnosis
- discuss challenges in distinguishing active and latent TB
- summarize current approaches to TB diagnosis
- describe prior art in MTB-specific cellular immune response
- highlight limitations of prior art
- introduce inventors' novel approach to TB diagnosis
- describe method of determining TB infection status
- outline advantages of inventors' method
- provide definitions of terms used in the invention
- describe preferred techniques for identifying T-cell subsets
- outline embodiments of the invention
- define TB infection status
- determine active TB infection
- determine latent TB infection
- determine risk of latent TB progressing to active TB
- determine time elapsed since TB infection
- describe method independence of HIV status
- describe method independence of TB infection site
- specify sample types for method
- describe method sensitivity and specificity
- describe antibody compositions for method
- define antigen-binding fragments
- describe methods of generating antibodies
- list suitable monoclonal antibodies
- describe antibody fragments preparation
- introduce fluorophores
- list examples of fluorophores
- describe use of fluorophores
- introduce composition for diagnosing TB infection
- describe method of treating TB infection
- introduce kit for determining TB infection status
- describe components of kit
- introduce additional components of kit
- define abbreviations
- describe figures
- introduce figure 1
- introduce figure 2
- introduce figure 3
- introduce figure 4
- introduce figure 5
- introduce figure 6 and 7

## EXAMPLES

- describe participant enrollment and selection
- outline IFN-γ ELISpot assay and intracellular cytokine staining
- detail data analysis and threshold settings
- explain statistical analysis methods
- introduce example analyses

### Example 1

- analyze frequency of CD4+ and CD8+ cells with IFN-γ and TNF-α+ response in ATB

### Example 2

- examine memory phenotype of CD4+ functional subsets in ATB vs LTBI
- analyze CD127 expression on antigen-specific CD4+ functional T-cell subsets

### Example 3

- investigate expansion of differentiated CD4+ functional effector T-cells in ATB vs LTBI
- evaluate potential of combined phenotypic and functional measurement as a clinical biomarker

### Example 4

- describe diagnosis of infection with MTB using ELISpot platforms

### Example 5

- introduce multi-parameter flow cytometry
- describe novel combination of cellular targets
- outline method for distinguishing active and latent TB infection
- discuss results of examples 1-3
- analyze association of TB disease stage with MTB-specific cellular immunity
- discuss impact of HIV co-infection on MTB-specific cellular immunity
- conclude on biomarker reliability and applicability

### Example 6

- demonstrate inverse correlation with time since estimated exposure to TB

